Protiva Brian 4/A
4/A · ADTRAN Holdings, Inc. · Filed Sep 2, 2022
Insider Transaction Report
Form 4/AAmended
Protiva Brian
DirectorCEO of ADVA
Transactions
- Exercise/Conversion
Common Stock
2022-08-23$10.58/sh+17,668$186,927→ 348,277.14 total - Sale
Common Stock
2022-08-23$24.64/sh−26,501$652,985→ 330,609.14 total - Exercise/Conversion
Common Stock
2022-08-23$7.04/sh+8,833$62,184→ 357,110.14 total - Exercise/Conversion
Stock Option
2022-08-23−17,668→ 0 totalExercise: $10.58From: 2020-05-16Exp: 2023-05-14→ Common Stock (17,668 underlying) - Exercise/Conversion
Stock Option
2022-08-23−8,833→ 52,997 totalExercise: $7.04From: 2022-05-16Exp: 2025-05-14→ Common Stock (8,833 underlying)
Holdings
- 88,326
Stock Option
Exercise: $19.08From: 2026-05-16Exp: 2029-05-14→ Common Stock (88,326 underlying) - 41,220
Stock Option
Exercise: $7.01From: 2024-05-16Exp: 2027-05-14→ Common Stock (41,220 underlying) - 19,361.03(indirect: By Spouse)
Common Stock
- 49,464
Stock Option
Exercise: $12.17From: 2025-05-16Exp: 2028-05-14→ Common Stock (49,464 underlying)
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.47 to $24.94, inclusive. The reporting person undertakes to provide to ADTRAN Holdings, Inc. (the Issuer), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.